Skip to main content

Advertisement

SpringerLink
Log in

Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

A number of molecular epidemiological studies have been conducted the screening for BRCA1 and BRCA2 mutations in breast cancer patients with a positive family history of breast and/or ovarian cancer and reported many common mutations in BRCA1 and BRCA2 associated in breast cancer in different population and different ethnicity. However, it’s still lack of a systematic analysis on these mutations. To comprehensively evaluate the frequency and distribution of common BRCA1 and BRCA2 mutations which associated with breast cancer risk, we address this issue through system review and meta-analysis on 29 relevant published studies by conducting a literature search on PubMed and CNKI. 20 common founder germline mutations were identified from all 29 studies and 4 of BRCA1 (5382insC, 185delAG, 3819del5 and 4153delA) and 2 of BRCA2 (4075delGT, 5802del4) mutations were repeatedly reported twice or more in different articles, respectively. For the BRCA1, after conducting meta-analysis, we found that the overall frequency of 5382insC was 0.09 (95% CI 0.06–0.12), the frequency of 185delAG was 0.07 (95% CI 0.01–0.13), the frequency of 3819del5 was 0.02 (95% CI 0.01–0.04) and the frequency of 4153delA was 0.06 (95% CI 0.03–0.09). For the BRCA2, the overall frequency of 4075delGT was 0.02 (95% CI 0.00–0.03) and the frequency of 5802del4 was 0.07 (95% CI 0.04–0.11). This article provides a set of common mutations for BRCA1 and BRCA2 mutation carriers and the results may help to explore frequencies of BRCA1 and BRCA2 mutations in a given population and will be of significance both for diagnostic testing and for epidemiological studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Miki Y et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71

    Article  PubMed  CAS  Google Scholar 

  2. Wooster R et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792. doi:10.1038/378789a0

    Article  PubMed  CAS  Google Scholar 

  3. Tavtigian SV et al (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12:333–337. doi:10.1038/ng0396-333

    Article  PubMed  CAS  Google Scholar 

  4. Narod SA et al (1995) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet 56(1):254–264

    PubMed  CAS  Google Scholar 

  5. Ford D et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676–689

    Article  PubMed  CAS  Google Scholar 

  6. Neuhausen SL (1999) Ethnic differences in cancer risk resulting from genetic variation. Cancer 86:2575–2582

    Article  PubMed  CAS  Google Scholar 

  7. Rebbeck TR (1999) Inherited genetic predisposition in breast cancer. A population-based perspective. Cancer 86:2493–2501

    Article  PubMed  CAS  Google Scholar 

  8. Struewing JP et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401–1408

    Article  PubMed  CAS  Google Scholar 

  9. Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer 83:1301–1308. doi:10.1054/bjoc.2000.1407

    Article  Google Scholar 

  10. Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232–242

    PubMed  CAS  Google Scholar 

  11. Schubert EL et al (1997) BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet 60:1031–1040

    PubMed  CAS  Google Scholar 

  12. Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56:265–271

    PubMed  CAS  Google Scholar 

  13. Sergentanis TN, Economopoulos KP (2010) Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls. Mol Biol Rep. doi:10.1007/s11033-010-0639-4

  14. Chen MB et al (2010) Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls. Mol Biol Rep. doi:10.1007/s11033-010-0603-3

  15. Mann GJ et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8:R12. doi:10.1186/bcr1377

    Article  PubMed  Google Scholar 

  16. McKean-Cowdin R et al (2005) BRCA1 variants in a family study of African-American and Latina women. Hum Genet 116:497–506. doi:10.1007/s00439-004-1240-5

    Article  PubMed  CAS  Google Scholar 

  17. Saxena S et al (2006) Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet 7:75. doi:10.1186/1471-2350-7-75

    Article  PubMed  Google Scholar 

  18. Peto J et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943–949. doi:10.1093/jnci/91.11.943

    Article  PubMed  CAS  Google Scholar 

  19. Spitzer E et al (2000) Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure. Int J Cancer 85:474–481. doi:10.1002/(SICI)1097-0215(20000215)85:4<474:AID-IJC5>3.0.CO;2-4

    Article  PubMed  CAS  Google Scholar 

  20. van Der Looij M et al (2000) Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. Hum Mutat 15:480–481. doi:10.1002/(SICI)1098-1004(200005)15:5<480:AID-HUMU13>3.0.CO;2-G

    Article  Google Scholar 

  21. Grzybowska E et al (2000) High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer. Hum Mutat 16:482–490. doi:10.1002/1098-1004(200012)16:6<482:AID-HUMU5>3.0.CO;2-O

    Article  PubMed  CAS  Google Scholar 

  22. Vaziri SA et al (2001) Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families. Hum Mutat 17:74. doi:10.1002/1098-1004(2001)17:1<74:AID-HUMU13>3.0.CO;2-I

    Article  PubMed  CAS  Google Scholar 

  23. Ikeda N et al (2001) Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91:83–88. doi:10.1002/1097-0215(20010101)91:1<83::AID-IJC1013>3.0.CO;2-5

  24. Palmieri G et al (2002) BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling. Ann Oncol 13:1899–1907. doi:10.1093/annonc/mdf326

    Article  PubMed  CAS  Google Scholar 

  25. Basham VM et al (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4:R2. http://breast-cancer-research.com/content/4/1/R2

  26. Tereschenko IV et al (2002) BRCA1 and BRCA2 mutations in Russian familial breast cancer. Hum Mutat 19:184. doi:10.1002/humu.9008

    Article  PubMed  Google Scholar 

  27. Meindl A (2002) Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97:472–480. doi:10.1002/ijc.1626

    Article  PubMed  CAS  Google Scholar 

  28. Patmasiriwat P et al (2002) Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer. Hum Mutat 20:230. doi:10.1002/humu.9049

    Article  PubMed  Google Scholar 

  29. Janiszewska H et al (2003) Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland. Clin Genet 64:502–508. doi:10.1046/j.1399-0004.2003.00178.x

    Article  PubMed  CAS  Google Scholar 

  30. Stuppia L et al (2003) BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy. Hum Mutat 22:178–179. doi:10.1002/humu.9164

    Article  PubMed  CAS  Google Scholar 

  31. Gorski B et al (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110:683–686. doi:10.1002/ijc.20162

    Article  PubMed  CAS  Google Scholar 

  32. Pal T et al (2004) BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev 13:1794–1799. http://cebp.aacrjournals.org/content/13/11/1794

  33. Hu Z et al (2004) [Analysis of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives]. Zhonghua Zhong Liu Za Zhi 26:657–659

    PubMed  CAS  Google Scholar 

  34. Pietschmann A et al (2005) Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families. J Cancer Res Clin Oncol 131:552–558. doi:10.1007/s00432-005-0678-8

    Article  PubMed  CAS  Google Scholar 

  35. van der Hout AH et al (2006) A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting. Hum Mutat 27:654–666. doi:10.1002/humu.20340

    Article  PubMed  Google Scholar 

  36. Song CG et al (2006) The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 132:617–626. doi:10.1007/s00432-006-0105-9

    Article  PubMed  CAS  Google Scholar 

  37. Ang P et al (2007) BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy. Cancer Epidemiol Biomarkers Prev 16:2276–2284. doi:10.1158/1055-9965.EPI-07-0403

    Article  PubMed  CAS  Google Scholar 

  38. Thomassen M et al (2008) BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer. Acta Oncol 47:772–777. doi:10.1080/02841860802004974

    Article  PubMed  CAS  Google Scholar 

  39. Ratajska M et al (2008) BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. Oncol Rep 19:263–268

    PubMed  CAS  Google Scholar 

  40. Besic N et al (2008) BRCA2 gene mutations in Slovenian male breast cancer patients. Genet Test 12:203–209. doi:10.1089/gte.2007.0071

    Article  PubMed  CAS  Google Scholar 

  41. Konstantopoulou I et al (2008) Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients. Breast Cancer Res Treat 107:431–441. doi:10.1007/s10549-007-9571-2

    Article  PubMed  CAS  Google Scholar 

  42. Miramar MD et al (2008) Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1. Breast Cancer Res Treat 112:353–358. doi:10.1007/s10549-007-9868-1

    Article  PubMed  CAS  Google Scholar 

  43. Neuhausen SL et al (2009) BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res Treat 116:379–386. doi:10.1007/s10549-008-0153-8

    Article  PubMed  CAS  Google Scholar 

  44. Cao MZ et al (2009) Analysis of BRCA1 mutations among familial and/or breast cancer praecox patients in the east of Shandong in China. Prog Mod Biomed 9:1028–1030 (in Chinese)

    Google Scholar 

  45. Infante M et al (2010) BRCA1 5272–1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin. Clin Genet 77:60–69. doi:10.1111/j.1399-0004.2009.01272.x

    Article  PubMed  CAS  Google Scholar 

  46. Vaidyanathan K et al (2009) BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation. J Biosci 34:415–422

    Article  PubMed  CAS  Google Scholar 

  47. Tamboom K et al (2010) BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia. Hered Cancer Clin Pract 8:4. doi:10.1186/1897-4287-8-4

    Article  PubMed  Google Scholar 

  48. Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  PubMed  CAS  Google Scholar 

  49. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

    Article  PubMed  CAS  Google Scholar 

  50. Shattuck-Eidens D et al (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273:535–541

    Article  PubMed  CAS  Google Scholar 

  51. Roa BB et al (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185–187. doi:10.1038/ng1096-185

    Article  PubMed  CAS  Google Scholar 

  52. Hartge P et al (1999) The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 64:963–970

    Article  PubMed  CAS  Google Scholar 

  53. Fodor FH et al (1998) Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet 63:45–51

    Article  PubMed  CAS  Google Scholar 

  54. Warner E et al (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91:1241–1247. doi:10.1093/jnci/91.14.1241

    Article  PubMed  CAS  Google Scholar 

  55. Levy-Lahad E et al (1997) Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 60:1059–1067

    PubMed  CAS  Google Scholar 

  56. Abeliovich D et al (1997) The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60:505–514

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Jiangsu Provincial Center for Disease Prevention and Control, Jiangsu Road 172, Nanjing, 210029, China

    Furu Wang, Ningle Yu, Sanxiao Xu & Xiangyong Fan

  2. Department of Respiratory Medicine, Nanjing Children’s Hospital Affiliated to Nanjing Medical University, Guangzhou Road, Nanjing, 210029, China

    Qiaoqiao Fang

  3. Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China

    Zhen Ge

Authors
  1. Furu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qiaoqiao Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhen Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ningle Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sanxiao Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiangyong Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Furu Wang.

Additional information

Furu Wang and Qiaoqiao Fang contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, F., Fang, Q., Ge, Z. et al. Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review. Mol Biol Rep 39, 2109–2118 (2012). https://doi.org/10.1007/s11033-011-0958-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-011-0958-0

Keywords

Search

Navigation